BostonGene
Performs integrated genomic and transcriptomic profiling of patient tumors and microenvironments.
What they do
BostonGene provides molecular profiling and advanced bioinformatics analysis for oncology patients. Its platform analyzes the genomic and immune microenvironment profile of tumors, delivering comprehensive reports that clinicians use to select personalized chemotherapy, immunotherapy, and targeted therapies.
The record
- Vertical
- Oncology
- Sub-segment
- Cancer screening and diagnostics
- Product type
- Diagnostics
- Stage
- Series B
- Headquarters
- Boston, United States
- Region
- North America
- Founded
- 2015
- Total funding
- $250M raised
Notable investors: NEC Corporation.